| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BA | Industrials | Citigroup | Maintains | Buy → Buy | — | $169.4B | $97.71 | +2.2% | -2.8% | +11.2% | +20.9% | +24.3% | +13.7% |
| TMO | Healthcare | Citigroup | Maintains | Buy → Buy | — | $168.8B | $280.84 | -1.2% | -0.9% | -8.3% | +10.5% | -3.7% | +4.2% |
| DHR | Healthcare | Citigroup | Maintains | Buy → Buy | — | $118.8B | $110.08 | +1.4% | -0.3% | -2.0% | +6.4% | +0.1% | +7.2% |
| ACN | Technology | Citigroup | Maintains | Buy → Buy | — | $113.3B | $158.50 | -0.6% | -5.4% | -4.2% | +9.2% | -3.2% | +12.9% |
| SLB | Energy | Citigroup | Maintains | Neutral → Neutral | — | $84.5B | $13.87 | +3.1% | +3.0% | -10.2% | +14.2% | -0.3% | +6.3% |
| EOG | Energy | Citigroup | Maintains | Buy → Buy | — | $77.8B | $33.22 | +4.4% | +5.0% | -1.0% | +15.2% | -0.3% | -0.4% |
| ROST | Consumer Cyclical | CitigroupC | Upgrade | Neutral → Buy | — | $68.7B | $65.00 | +0.7% | -1.7% | -1.5% | +13.8% | +13.6% | +5.3% |
| BKR | Energy | Citigroup | Maintains | Buy → Buy | — | $66.4B | $10.14 | +0.5% | -1.4% | -6.7% | +20.6% | +3.3% | +6.7% |
| HAL | Energy | Citigroup | Maintains | Neutral → Neutral | — | $36.1B | $4.80 | +6.9% | +5.2% | +3.8% | +26.5% | +2.1% | +4.1% |
| A | Healthcare | Citigroup | Maintains | Neutral → Neutral | — | $32.3B | $65.76 | +0.3% | +1.1% | -4.6% | +5.7% | +3.0% | +6.8% |
| ILMN | Healthcare | Citigroup | Maintains | Buy → Buy | — | $21.8B | $218.47 | +3.3% | +7.6% | -1.8% | +6.9% | -2.3% | +10.5% |
| ULTA | Consumer Cyclical | CitigroupC | Upgrade | Neutral → Buy | — | $21.7B | $146.99 | +6.4% | +0.7% | -3.3% | +24.0% | +8.0% | -1.6% |
| MTD | Healthcare | Citigroup | Maintains | Neutral → Neutral | — | $21.7B | $721.43 | -0.4% | -10.6% | -8.6% | +9.5% | -0.8% | +3.0% |
| WAT | Healthcare | Citigroup | Maintains | Sell → Sell | — | $19.9B | $177.42 | +0.6% | -2.2% | -6.4% | +11.3% | -2.1% | +8.3% |
| LULU | Consumer Cyclical | CitigroupC | Upgrade | Neutral → Buy | — | $14.2B | $154.86 | +5.6% | +6.6% | +4.4% | +11.9% | +0.5% | +3.7% |
| BIO | Healthcare | Citigroup | Maintains | Buy → Buy | — | $7.9B | $346.80 | +0.2% | -5.1% | -0.8% | +5.2% | -3.0% | +2.5% |
| TECH | Healthcare | Citigroup | Maintains | Neutral → Neutral | — | $7.3B | $41.61 | -1.1% | +0.5% | +1.8% | -0.3% | +1.5% | +8.0% |
| BRKR | Healthcare | Citigroup | Maintains | Neutral → Neutral | — | $6.7B | $35.81 | -0.6% | -4.0% | -7.3% | +8.3% | +5.9% | +9.8% |
| AVTR | Healthcare | Citigroup | Maintains | Buy → Buy | — | $5.4B | $10.31 | +0.7% | +1.0% | -2.2% | +12.5% | -2.9% | +8.7% |
| OLLI | Consumer Defensive | Citigroup | Maintains | Neutral → Neutral | — | $4.9B | $38.06 | -5.2% | +1.9% | +3.4% | +3.5% | +0.4% | +1.8% |